Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Coherus BioSciences, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 19.215||$ 38.10|
|Low||$ 18.40||$ 12.04|
The current last sale of $18.83 is 56.40% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a late-stage clinical biologics platform company focused on the global biosimilar market. Biosimilars are an emerging class of protein-based therapeutics with high similarity to approved originator products on the basis of various physicochemical and structural properties, as well as in terms of safety, purity and potency. Our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Since our founding in 2010, we have advanced three product candidates into Phase 3 or Biologics License Application (BLA), enabling clinical development and entered into partnerships with two global pharmaceutical companies and one strategic biologics manufacturer. ... More ...
Where does CHRS fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-6.01|
|Quarterly EPS Est:||-1.42|